BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, February 13, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 18, 2011
View Archived Issues
Promising data disclosed from PEPPER trial of Pantera Lux paclitaxel-releasing balloon
Read More
New activators of nuclear receptor related 1 receptor claimed
Read More
In vitro profile supports first-in-human study of GSK-2336805 for hepatitis C
Read More
HM-781-36B displays potent inhibitory effects in erbB-1-dependent tumors
Read More
Treatment of hepatitis C with IDX-184 is not linked to resistance mutations
Read More
ADVENTRX acquires SynthRX and poloxamer-188
Read More
Czech researchers present new platinum complexes with antitumor activity
Read More
Niacin reduces phosphate levels in subjects with hyperphosphatemia due to hemodialysis
Read More
Viralytics cleared to dose final patient group in phase I Cavatak study
Read More
Delcath receives CE mark for Hepatic Chemosat delivery system
Read More
Bayer's oral anticoagulant rivaroxaban submitted for Japanese approval
Read More
Takeda to participate in phase III trial of Amgen's AMG-479 in metastatic pancreatic cancer
Read More
Terumo expands blood management business with acquisition of CaridianBCT
Read More
Debiopharm and Augifene Discovery Technologies partner for Debio-1142
Read More
S*BIO doses first patients in phase II trial of SB-1518 in advanced lymphoid malignancies
Read More
Quest PharmaTech and Hemispherx to study combinatorial immunotherapy technology
Read More
SDD-formulated bardoxolone methyl shows promise in patients with diabetes and chronic kidney disease
Read More
Humanized MAb reverses dabigatran-induced anticoagulation in preclinical study
Read More
Preclinical and clinical data presented on TRIN-2755 for solid tumors/sarcomas
Read More
Novel lysophospholipid S1P1 receptor agonists described by Almirall
Read More
N30 Pharma presents new inhibitors of alcohol dehydrogenase class-3
Read More
ChemoCentryx presents new CMKLR1 receptor ligands
Read More
CHMP adopts positive opinion on Avastin/Xeloda combination in metastatic breast cancer
Read More
FDA approves Actemra for systemic juvenile idiopathic arthritis
Read More
CHMP recommends approval of once-weekly exenatide for type 2 diabetes
Read More
Active Biotech and Ipsen to codevelop and commercialize tasquinimod for cancer
Read More
FDA requests additional trial for Lilly's liprotamase NDA in exocrine pancreatic insufficiency
Read More
ARCA biopharma gains worldwide rights to genetic markers for chronic heart failure candidate Gencaro
Read More
Pfizer reports topline data from phase III ORAL Scan trial of tofacitinib in rheumatoid arthritis
Read More
Amarin's phase III ANCHOR trial of AMR-101 meets primary endpoint
Read More
Teva Pharma's lansoprazole delayed-release ODT withdrawn from distribution
Read More
CHMP recommends approval of dabigatran etexilate for prevention of stroke in patients with AF
Read More
